Table 4.
Results of gallium-67 scintigraphy in the subgroup of patients with kidney biopsy
| Patient | Posterior planar grade | SPECT grade | Comment | Time intervala (days) |
|---|---|---|---|---|
| AIN (Group 1) | ||||
| 1 | 1 | 1 | Drug-induced AIN (cloxacilline) | 11 |
| 2 | 2 | 3 | Drug-induced AIN (ranitidine) | 67 |
| 3 | 3 | 3 | Sjögren syndrome | 159 |
| 4 | 4 | 4 | Drug induced AIN (pantoprazole) | 19 |
| 5b | 4 | 5 | AIN of uncertain etiology | 65 |
| 6 | 4 | 4 | Drug-induced AIN | 4 |
| 7 | 5 | 5 | AIN induced by natural products | 4 |
| 8 | 5 | 5 | Drug-induced AIN (ciprofloxacin) | 26 |
| Other diagnosis (Group 2) | ||||
| 9 | 1 | 1 | Mild chronic TI changes | 54 |
| 10b | 1 | 1 | Glomerulosclerosis, chronic TI changes | 40 |
| 11 | 1 | N/A | Pauci-immune crescentic GN | 7 |
| 12 | 1 | 1 | Pauci-immune crescentic GN, interstitial infiltrates | 23 |
| 13 | 1 | 1 | Glomerulosclerosis, chronic TI changes | 10 |
| 14 | 1 | 2 | Hypertensive nephropathy | 24 |
| 15 | 2 | 2 | Membranoproliferative GN | 23 |
| 16 | 2 | 2 | No significant histologic changes | 28 |
| 17b | 3 | 3 | IgA nephropathy | 37 |
| 18 | 4 | 4 | Pauci-immune crescentic GN | 8 |
| 19 | 4 | 4 | Glomerulosclerosis | 105 |
| 20 | 4 | 4 | Mild tubular atrophy | 48 |
TI, tubulointerstitial; GN, glomerulonephritis; N/A, Not available.
aTime interval between gallium scintigraphy and kidney biopsy.
bKidney transplant recipient.